Relx Plc (NYSE:RELX) Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lessened its stake in Relx Plc (NYSE:RELX - Free Report) by 10.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,709 shares of the technology company's stock after selling 4,767 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Relx were worth $2,103,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. Private Trust Co. NA lifted its holdings in Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after buying an additional 199 shares during the last quarter. Sage Mountain Advisors LLC boosted its holdings in Relx by 5.1% in the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock worth $240,000 after purchasing an additional 258 shares during the period. DRW Securities LLC increased its stake in Relx by 5.9% during the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock valued at $211,000 after purchasing an additional 259 shares during the last quarter. Kovitz Investment Group Partners LLC increased its stake in Relx by 3.4% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock valued at $371,000 after purchasing an additional 267 shares during the last quarter. Finally, Ascent Group LLC raised its holdings in shares of Relx by 2.0% during the fourth quarter. Ascent Group LLC now owns 14,024 shares of the technology company's stock worth $637,000 after purchasing an additional 277 shares during the period. Institutional investors own 15.02% of the company's stock.

Relx Stock Performance

Shares of NYSE:RELX traded down $1.26 on Wednesday, hitting $52.65. The company's stock had a trading volume of 971,419 shares, compared to its average volume of 738,318. The company has a market capitalization of $98.86 billion, a price-to-earnings ratio of 28.30, a price-to-earnings-growth ratio of 3.27 and a beta of 0.83. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. Relx Plc has a 12 month low of $43.45 and a 12 month high of $56.33. The stock's 50-day moving average is $53.82 and its two-hundred day moving average is $50.45.

Analysts Set New Price Targets

RELX has been the topic of a number of recent research reports. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Morgan Stanley restated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. Wall Street Zen cut Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Finally, The Goldman Sachs Group initiated coverage on shares of Relx in a research report on Wednesday, March 26th. They set a "buy" rating for the company. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy".

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.